Call for FDA Oversight: AKA Demands Regulation of Kratom Market

The American Kratom Association (AKA) has recently stepped up to demand that the U.S. Food and Drug Administration (FDA) take regulatory action on kratom, a plant native to Southeast Asia. Currently, in the U.S., kratom is not officially regulated as a drug, dietary supplement, or food additive, despite its widespread availability. The AKA has raised concerns over the FDA’s generalized treatment of all kratom products, which they argue leaves consumers without proper guidance in a market that can be confusing and unsafe. The association is pushing for the FDA to step in and provide regulations that would help consumers distinguish between safe and potentially harmful kratom products, highlighting the importance of consumer safety in this expanding market. To delve deeper into this development, visit the original article on Food Safety News.